| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.063 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |